Back to results
US 6,184,216 B2Granted
Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
AssigneePharmacia & Upjohn Company
InventorsScott D. Larsen, Martin D. Meglasson, Valerie A. Vaillancourt, Paul D. May
Life of this patent
Estimating the term…
Abstract
Compounds selected from the group consisting of formulae III, IV, VI and VIII wherein R is H is NH2, or a pharmacologically acceptable salt thereof, are suitable for use in methods for treating non-insulin-dependent diabetes mellitus (NIDDM) or obesity in a patient susceptible to or experiencing NIDDM or obesity by the systemic administration of such a compound in an amount effective to treat the NIDDM or obesity.
Claims10
A compound selected from the group consisting of formulae III, IV, VI and VII
- wherein R is H or NH2, or a pharmacologically acceptable salt thereof.
Dependencies are inferred from the claim text.